A director at Dermapharm Holding SE bought 100,000 shares at 34.940EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
AUCTUS PUBLICATIONS ________________________________________ Chariot (CHAR LN)C; Under review: Potential demerger – The management of Chariot is considering splitting the company in two entities, one focusing on upstream oil and gas and the other on renewable power. The latter will also house the hydrogen and water assets. Pending further details, we are placing the company under review. New Zealand Energy (NZ CN)C: Operating update in New Zealand. Equity raise – The copper Moki-2 well has bee...
Orano warns of bankruptcy of its subsidiary in Niger|Afflelou: S&P and Fitch maintain ratings and outlooks stable after dividend|Maxeda: excellent Q1 results, debt buybacks continue, no comment on the refinancing|Bouygues and Iliad are reportedly discussing a split of SFR (BFM Business)|
Orano alerte sur la faillite de sa filiale au Niger|Afflelou : S&P et Fitch maintiennent les ratings et outlooks stables après le dividende|Maxeda : très bons résultats T1, les rachats de dettes se poursuivent, pas de commentaires sur le refinancement|Bouygues et Iliad discuteraient d’un partage de SFR (BFM Business)|
A director at Intesa Sanpaolo S.p.A. sold 158,273 shares at 4.866EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.